Mintz announced that two new Members, Scott Lashway and Chris Lisy, have joined the firm’s Boston office in its Data & Privacy Litigation and Investigations Practice. “Cybersecurity and data privacy continue to […]
Mintz Adds Leading Data Privacy and Cybersecurity Litigators in Boston
Mintz Adds Top Trademark Practitioner to San Francisco Office
Mintz announced that Laura M. Franco has joined as a Member of the Intellectual Property practice group in the firm’s San Francisco office. Laura is an internationally recognized...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
Hyperfine and Liminal’s $580 Million Business Combination with HealthCor Catalio Acquisition Corp.
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo and Conyers advised Hyperfine and Liminal Sciences on the deal, while Kirkland & Ellis counseled HealthCor Catalio Acquisition Corp....
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
Aspen Aerogels’ $75 Million Private Placement with Koch Strategic Platforms
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo advised Aspen Aerogels, Inc. on the deal. Aspen Aerogels, Inc. (NYSE: ASPN) (Aspen), a technology leader in sustainability, announced...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
Aspen Aerogels’ $75 Million Private Placement with Koch Strategic Platforms
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo advised Aspen Aerogels, Inc. on the deal. Aspen Aerogels, Inc. (NYSE: ASPN) (Aspen), a technology leader in sustainability, announced...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
Q2 Solutions’ Acquisition of Myriad RBM
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo advised Myriad Genetics, Inc. on the deal. Myriad Genetics, Inc. (NASDAQ: MYGN), a genetic testing and precision medicine company,...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
Q2 Solutions’ Acquisition of Myriad RBM
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo advised Myriad Genetics, Inc. on the deal. Myriad Genetics, Inc. (NASDAQ: MYGN), a genetic testing and precision medicine company,...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
Nuvve’s $750 Million Joint Venture with Stonepeak Partners LP
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo advised Nuvve on the deal, while Kirkland & Ellis counseled Stonepeak Partners. Nuvve Holding Corp. (Nuvve) (Nasdaq: NVVE), a...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
Humana’s Acquisition of Kindred at Home
Fried, Frank, Harris, Shriver & Jacobson LLP and Manatt, Phelps & Phillips LLP advised Humana, while Debevoise & Plimpton LLP and Mintz advised TPG Capital (TPG)...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
Vicarious Surgical’s $1.1 Billion SPAC Merger with D8 Holdings Corp.
Mintz advised Vicarious Surgical Inc. on the deal. Vicarious Surgical Inc., a next-generation robotics technology company seeking to improve both cost and efficiency of surgical procedures...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here